Biography
Norbert Pardi
Dr. Norbert Pardi holds a Ph.D. in biochemistry and genetics obtained from the University of Szeged, Hungary. He has been working at the University of Pennsylvania since 2011. During his postdoctoral work he was trained in the laboratories of Dr. Katalin Kariko and Dr. Drew Weissman. Dr. Pardi currently holds an Associate Professor position at the Department of Microbiology of the Perelman School of Medicine. His research interest is the development of mRNA-based therapeutics with particular focus on new generation infectious disease vaccines. He explored the development of a novel vaccine platform using nucleoside-modified mRNA in lipid nanoparticles (LNPs) and used it to generate highly effective vaccines targeting various pathogens (influenza virus, coronaviruses, malaria and others). Dr. Pardi is a pioneer of the nucleoside-modified mRNA vaccine technology and published milestone papers in the field.